NIMA Partners, EmpowerDx Collaborate on Celiac Gene Test
The assay from EmpowerDx uses self-collected oral swabs to identify genetic risk for the autoimmune disease, and the companies offer results within 10 business days.
Gut Microbiome Study in Infants Identifies Alterations That May Contribute to Celiac Disease
The researchers said their approach could be used to predict disease onset and, ultimately, to identify early preventive interventions.
Adaptive Biotechnologies ImmunoSeq Dx Development Jolts Forward With Lyme Disease in Crosshairs
The immune sequencing firm has engaged the FDA in discussions over how to get regulatory approval for one test for several seemingly different diseases.
Beyond Celiac Grants $160K for Transcriptomics Pilot Study
The award will go to Jocelyn Silvester of Children's Hospital Boston, to fund transcriptomics research on intestinal inflammation caused by gluten.
The immune sequencing firm is working on kit-ifying its two existing tests, as well as developing a second clinical test and expanding the label for clonoSeq.